Episodic Cancer Pain: Patient Reporting, Prevalence, and Clinicodemographic Associations at Initial Cancer Pain Clinic Assessment

Joint Authors

Reis-Pina, Paulo
Acharya, Anand
Barbosa, Antonio
Lawlor, Peter G.

Source

Pain Research and Management

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-11, 11 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-05-22

Country of Publication

Egypt

No. of Pages

11

Main Subjects

Diseases

Abstract EN

Background.

Better understanding of the episodic cancer pain (CP) spectrum, including pains that occur in addition to its conventionally defined breakthrough CP (BTcP) and incident CP (IcP) components, may inform CP assessment and management.

This study aimed to determine the prevalence of episodic patient-reported CP and the prevalence and associations of study-defined BTcP (S-BTcP) and IcP (S-IcP) in patients with CP.

Methods.

In a cross-sectional study at their first CP clinic attendance, participants with CP had the following assessments: Brief Pain Inventory (BPI); Pain Management Index (PMI), with PMI-negative status indicating undertreatment; standardized neuropathic pain component (NPC) status; S-BTcP (no trigger identified) and S-IcP (trigger identified) status, based on a preceding 7-day history of transitory pain flares distinct from background pain, and BPI-Worst or BPI-Now pain intensity ≥ 4.

Clinicodemographic variables’ association with S-BTcP and S-IcP was examined in logistic regression analyses.

Results.

Of 371 participants, 308 (83%) had episodic CP by history alone; 140 (37.7%) and 181 (48.8%) had S-BTcP and S-IcP, respectively.

Multivariable analyses demonstrated significant (p<0.05) associations (odds ratios: 95% CIs) for 6 variables with S-BTcP: head and neck pain location (2.53; 1.20–5.37), NPC (2.39; 1.34–4.26), BPI average pain (1.64; 1.36–1.99), abdominal pain (0.324; 0.120–0.873), S-IcP (0.207; 0.116–0.369), and PMI-negative status (0.443; 0.213–0.918).

Similar independent associations (p<0.05) occurred for S-IcP with NPC, BPI average pain, and PMI-negative status, in addition to radiotherapy, S-BTcP, soft tissue pain, and sleep interference.

Conclusions.

Episodic or transient patient-reported CP flares often do not meet the more conventional criteria that define BTcP and IcP, the principal episodic CP types.

Both BTcP and IcP occur frequently and both are associated with a NPC, higher pain intensity, and less opioid underuse in the management of CP.

Further studies are warranted to both better understand the complex presentations of episodic CP and inform its classification.

American Psychological Association (APA)

Reis-Pina, Paulo& Acharya, Anand& Barbosa, Antonio& Lawlor, Peter G.. 2020. Episodic Cancer Pain: Patient Reporting, Prevalence, and Clinicodemographic Associations at Initial Cancer Pain Clinic Assessment. Pain Research and Management،Vol. 2020, no. 2020, pp.1-11.
https://search.emarefa.net/detail/BIM-1206912

Modern Language Association (MLA)

Reis-Pina, Paulo…[et al.]. Episodic Cancer Pain: Patient Reporting, Prevalence, and Clinicodemographic Associations at Initial Cancer Pain Clinic Assessment. Pain Research and Management No. 2020 (2020), pp.1-11.
https://search.emarefa.net/detail/BIM-1206912

American Medical Association (AMA)

Reis-Pina, Paulo& Acharya, Anand& Barbosa, Antonio& Lawlor, Peter G.. Episodic Cancer Pain: Patient Reporting, Prevalence, and Clinicodemographic Associations at Initial Cancer Pain Clinic Assessment. Pain Research and Management. 2020. Vol. 2020, no. 2020, pp.1-11.
https://search.emarefa.net/detail/BIM-1206912

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1206912